0001493152-20-017640.txt : 20200911 0001493152-20-017640.hdr.sgml : 20200911 20200911161720 ACCESSION NUMBER: 0001493152-20-017640 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200910 FILED AS OF DATE: 20200911 DATE AS OF CHANGE: 20200911 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GLECKEL LOUIS MD CENTRAL INDEX KEY: 0001164762 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21617 FILM NUMBER: 201171128 MAIL ADDRESS: STREET 1: C/O PROHEALTH CARE ASSOCIATES LLP STREET 2: 2800 METRUS AVE CITY: LAKE SUCCESS STATE: NY ZIP: 11042 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ProPhase Labs, Inc. CENTRAL INDEX KEY: 0000868278 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232577138 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 621 N. SHADY RETREAT ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18901 BUSINESS PHONE: 2153450919 MAIL ADDRESS: STREET 1: 621 N. SHADY RETREAT ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18901 FORMER COMPANY: FORMER CONFORMED NAME: QUIGLEY CORP DATE OF NAME CHANGE: 19930328 4 1 ownership.xml X0306 4 2020-09-10 0 0000868278 ProPhase Labs, Inc. PRPH 0001164762 GLECKEL LOUIS MD 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 1 0 0 0 Option (right to buy) 2.83 2020-09-10 4 A 0 100000 0.00 A 2027-09-09 Common Stock 100000 100000 D The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock, with one-quarter of such stock option vesting on September 30, 2020 and the remaining portion vesting pro rata in equal monthly installments beginning October 31, 2020 and on the last day of each month thereafter, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of September 10, 2020. /s/ Louis Gleckel, MD 2020-09-11